U.S. Capital Wealth Advisors LLC decreased its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 21.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 397,425 shares of the biopharmaceutical company’s stock after selling 105,745 shares during the quarter. U.S. […]
Legacy Financial Advisors Inc. lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 8.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,287 shares of the biopharmaceutical company’s stock after selling 2,291 shares during the quarter. Legacy Financial […]
Pfizer (NYSE:PFE – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.15-2.35 for the period, compared to the consensus EPS estimate of $2.21. The company issued revenue guidance of $58.5-61.5 billion, compared to the consensus revenue estimate of $59.94 billion. Pfizer also updated […]
Pfizer (NYSE:PFE – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $2.15-2.35 for the period, compared to the consensus EPS estimate of $2.21. The company issued revenue guidance of $58.5-61.5 billion, compared to the consensus revenue estimate of $59.94 billion. Pfizer also updated its FY 2024 guidance […]
Pfizer (NYSE:PFE – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $2.15-2.35 for the period, compared to the consensus earnings per share estimate of $2.21. The company issued revenue guidance of $58.5-61.5 billion, compared to the consensus revenue estimate of $59.94 billion. Pfizer also updated […]